Basal Ganglia Pathophysiology Unit, Dept. Experimental Medical Science, Lund University, Lund, Sweden.
Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Philadelphia, Pennsylvania, USA.
Mov Disord. 2019 Nov;34(11):1699-1710. doi: 10.1002/mds.27810. Epub 2019 Aug 26.
Cortical α-synuclein pathology plays a role in the development of cognitive dysfunction in both Parkinson's disease and dementia with Lewy bodies, although the causative cellular lesions have remained unclear. We aimed to address causal links between α-synuclein-driven pathology in the cerebral cortex and the development of cognitive impairments using new experimental models.
Neuronal overexpression of human α-synuclein was induced in the rat medial prefrontal cortex using viral vectors. This was combined with inoculations of preformed fibrils of human α-synuclein in some animals. Rats were evaluated with tests probing prefrontal cognitive functions (delayed matching/nonmatching to position and 5-choice serial reaction time task). Patterns of neuropathology were characterized immunohistochemically.
Neither α-synuclein overexpression nor the fibril seeds alone yielded any behavioral phenotype. In contrast, combining the 2 approaches produced significant impairments in working memory, attention, and inhibitory control. All animals injected with α-synuclein vectors exhibited high immunoreactivity for human α-synuclein in the medial prefrontal cortex and its primary projection targets. However, only when this overexpression was combined with fibril inoculations did animals exhibit large, proteinase K-resistant and Ser -phosphorylated α-synuclein intraneuronal inclusions in the medial prefrontal cortex and its closely interconnected brain regions. The inclusions were associated with distorted dendritic morphologies and partial neuronal loss in the targeted cortical areas.
Cortical overexpression of human α-synuclein is not sufficient to produce cognitive dysfunction, whereas combining this overexpression with fibril seeds yields both cognitive and histopathological phenotypes that are relevant to human Lewy body disease. © 2019 International Parkinson and Movement Disorder Society.
皮质α-突触核蛋白病理学在帕金森病和路易体痴呆的认知功能障碍发展中起作用,尽管其致病的细胞病变仍不清楚。我们旨在使用新的实验模型来解决大脑皮质中α-突触核蛋白驱动的病理学与认知障碍发展之间的因果关系。
使用病毒载体在大鼠前额皮质中诱导神经元过表达人α-突触核蛋白。在一些动物中,将人α-突触核蛋白的预形成原纤维接种于此。使用测试评估大鼠前额认知功能(位置延迟匹配/不匹配和 5 选择序列反应时间任务)。用免疫组织化学方法对神经病理学模式进行特征描述。
单独过表达α-突触核蛋白或原纤维种子都没有产生任何行为表型。相比之下,将这两种方法结合使用会导致工作记忆、注意力和抑制控制方面的显著障碍。所有接受α-突触核蛋白载体注射的动物在前额皮质及其主要投射靶区中均表现出高水平的人α-突触核蛋白免疫反应性。然而,只有当这种过表达与纤维接种相结合时,动物才会在前额皮质及其紧密相互连接的脑区中表现出大量、蛋白水解酶抗性和 Ser-磷酸化的α-突触核蛋白内包含物。包含物与靶向皮质区域中扭曲的树突形态和部分神经元丢失有关。
皮质中过表达人α-突触核蛋白不足以引起认知功能障碍,而将这种过表达与纤维种子结合使用会产生与人类路易体病相关的认知和组织病理学表型。© 2019 国际帕金森和运动障碍学会。